| Revenue growth | 15.2% YoY growth for FY26 to ₹1,499.8cr. |
|---|---|
| Margins | EBITDA margins stable at 22.9% for the full year. |
| Demand visibility | Strong local demand in urban clusters of Mumbai and Pune. |
| Management confidence | Confident, emphasizing early commissioning of the Dombivli hospital. |
Growth
FY26 revenue grew 15.2% to ₹1,499.8cr, driven by improved ARPOB and volume growth across existing facilities.
Outlook
Commissioning Dombivli ahead of schedule and planning 1,700 new beds to reach 3,000 beds long-term.
Risks
High concentration in Mumbai/Pune; potential execution delays or cost overruns at the large-scale BKC project.
Earnings Call filed with NSE, NSE: JLHL. Summary written with AI assistance from the document.
Jupiter Life Line Hospitals Ltd: key numbers
- Share price
- ₹248.55
- Market cap
- ₹8,148 Cr
- Revenue (annual)
- ₹1,500 Cr
- Net profit (annual)
- ₹194.0 Cr
- P/E (TTM)
- 43.4×Sector 53.1×
- Promoter holding
- 40.91%+0.00% QoQ
- FII holding
- 9.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jupiter Life Line Hospitals Ltd
All →Jupiter Life Line Hospitals Earnings Call Transcript: Key Takeaways
Management is optimistic as the new Dombivli hospital ramps up, despite it causing a 9.5 crore EBITDA drag this quarter.
Jupiter Life Line Hospitals Other Announcement
Jupiter Life Line Hospitals Limited has authorized specific Key Managerial Personnel for determining and disclosing material events under SEBI Regulation 30(5).
Jupiter Life Line Hospitals Management Change
Jupiter Life Line Hospitals Limited has appointed Mr. Harshad Gaurishankar Purani as the new Chief Financial Officer, effective July 31, 2026.
Jupiter Life Line Hospitals Merger & Restructuring Worth ₹3.78 Cr
Jupiter Life Line Hospitals' subsidiary, Jupiter Hospital Pharmacy, acquired 100% of Sulcus Private Limited for ₹3.78 Crore. This move aims to expand pharmaceutical manufacturing capabilities.
- Value
- ₹3.78 Cr
Jupiter Life Line Hospitals Investor Presentation: Key Takeaways
Jupiter Life Line Hospitals reported Q1FY27 revenue growth of 16.2% YoY, while PAT declined 14.7% due to higher depreciation and finance costs from the new Dombivli facility.
Jupiter Life Line Hospitals Q1 FY27 Results: Net Profit ₹37.5 Cr, Down 14.6% YoY
Jupiter Life Line Hospitals Ltd reported revenue from operations of ₹411 Cr (+16.4% YoY) and net profit of ₹37.5 Cr (-14.6% YoY) for Q1 FY27.
- Key figure
- Net profit ₹37.5 Cr · -14.6% YoY